SM
IMMU

SG3 Management’s Immunomedics Inc IMMU Stock Holding History

SG3 Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,100
Closed -$1.54M – 1314
2020
Q3 		$1.54M Sell
18,100
-41,900
-70% -$2.12M 0.06% 324
2020
Q2 		$2.13M Buy
60,000
+55,000
+1,100% +$1.61M 0.15% 177
2020
Q1 		$67K Buy
+5,000
New +$84.1K 0.01% 308

SG3 Management's IMMU Position: Q3 2020 in Review

SG3 Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 27,500 shares — an estimated $1.39M sold.

SG3 Management first reported a position in IMMU in Q2 2020 and held it in 1 quarter. The position peaked at $975K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • SG3 Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • SG3 Management sold 27,500 Immunomedics Inc shares in Q3 2020, an estimated $1.39M.
  • SG3 Management first reported a position in Immunomedics Inc in Q2 2020 and held it in 1 quarter.
  • SG3 Management's Immunomedics Inc position peaked at $975K in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on SG3 Management's 13F filing for Q3 2020, filed 13 Nov 2020.